Technical Analysis for KRYS - Krystal Biotech, Inc.

Grade Last Price % Change Price Change
grade F 39.91 -0.03% -0.01
KRYS closed down 0.03 percent on Friday, August 7, 2020, on 50 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical KRYS trend table...

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Multiple of Ten Bearish Other 0.00%
Inside Day Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction -0.03%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Krystal Biotech, Inc. gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Company’s products include KB103 and KB104.The Compnay's KB103 is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. The Compnay's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, dehydration and stunted growth.
Medicine Rare Diseases Gene Therapy Medical Genetics Genodermatoses Genetic Genealogy Herpes Simplex Virus Dermatological Diseases Epidermolysis Bullosa Ichthyosis Itchiness Netherton Syndrome

Is KRYS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 66.85
52 Week Low 31.89
Average Volume 161,341
200-Day Moving Average 49.77
50-Day Moving Average 43.62
20-Day Moving Average 41.32
10-Day Moving Average 41.57
Average True Range 2.37
ADX 13.66
+DI 12.22
-DI 18.84
Chandelier Exit (Long, 3 ATRs ) 37.64
Chandelier Exit (Short, 3 ATRs ) 44.79
Upper Bollinger Band 44.02
Lower Bollinger Band 38.61
Percent B (%b) 0.24
BandWidth 13.09
MACD Line -0.85
MACD Signal Line -0.81
MACD Histogram -0.0312
Fundamentals Value
Market Cap 384.87 Million
Num Shares 9.64 Million
EPS -0.63
Price-to-Earnings (P/E) Ratio -63.35
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 42.00
Resistance 3 (R3) 42.09 41.49 41.65
Resistance 2 (R2) 41.49 40.96 41.44 41.53
Resistance 1 (R1) 40.70 40.63 40.40 40.61 41.42
Pivot Point 40.10 40.10 39.95 40.05 40.10
Support 1 (S1) 39.31 39.57 39.01 39.22 38.40
Support 2 (S2) 38.71 39.24 38.66 38.29
Support 3 (S3) 37.92 38.71 38.17
Support 4 (S4) 37.83